Overzicht Proefschriften

Tips in using the search/filter fields

Tips in using the search/filter fields
Select on a part of the content: ede Select exactly on a certain content: =ede
Select all fields that are NOT empty: >'' (two single quotes) Select all fields that are empty: =[spatie]
Select everything after a certain date: >31-12-2010 Select everything before a certain date: <31-12-2010
Select on a period containing the given date: >31-12-2010<1-2-2011 Type nu in a 'date' field to select everything between yesterday and tomorrow
By clicking a column title the table will be sorted on this column. If you then click the title of another column, the sort will be on this second column, preserving the first sort.
So if you want to sort on City and witghin that on Name, first click teh Name column and after that the City column. Click Reset to reset the filters and sorting.
Filters an sorting are saved and will be restored when you come back to this screen. Click Reset to reset the filters and sorting.
Go to page:
  • of 6

Displaying 1-50 of 278 results.
TitelPromovendusPromotor 1Promotor 2Copromotor 1Copromotor 2UniversiteitPromotiejaarTrefwoorden
Angiotensin II-induced vasodilation: role of bradykinin, NO and endothelium-derived hyperpolarizing factorsBatenburg W.W., dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2005Cardiovascular disease; Pharmacology;
Cardiac aldosterone: origin and effectsChai W., dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2005Cardiovascular disease; Pharmacology;
Unraveling the complexities of the renin-angiotensin system: from ACE to renin inhibitionEsch J.H.M. van, dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2008Cardiovascular disease; Pharmacology; Renin-angiotensin system;
(Pro)renin revisited: new insights from studies in mast cellsKrop M., dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2009Cardiovascular disease; Pharmacology; Prorenin;
Aortic pathology and the role of the renin-angiotensin systemMolzer E., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2011Pharmacology; Cardiovascular disease; Renin-angiotensin system;
The more complex renin-angiotensin system: new insights into an old systemGembardt F., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2011Pharmacology; Renin-angiotensin system;
Cardiovascular, renal and thyroid toxicity during angiogenesis inhibition: a translational approachKappers M.H.W., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2011Cancer; Pharmacology; Antihypertensive drugs;
The role of aldosterone and aldosterone blockade in hypertensionJansen P.M., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2013Cardiovascular disease; Antihypertensive drugs; Pharmacology;
Preeclampsia, the renin-angiotensin-aldosterone system and beyondVerdonk K., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2015Pre-eclampsia; Antihypertensive drugs; Pharmacology; Primary care; Renin-angiotensin system;
Neuropharmacology of novel dopamine modulators Beek E.T te, PhDGerven J.M.A. van, prof. dr.Cohen A.F., prof. dr.Universiteit Leiden (UL)2014Dopamine Antagonist Drug development Pharmacokinetics Pharmacodynamics Schizophrenia Drug addiction Tachykinins
Drug-induced psychomimetic symptoms as a model for psychosisKleinloog-Fernández González H.D., PhDGerven J.M.A. van, prof. dr.Cohen A.F., prof. dr.Universiteit Leiden (UL)2014Clinical Pharmacology Psychotic Disorders Clinical Trial Drug evaluation Biological Models
Novel approaches in clinical development of cannabinoid drugs Klumpers L.E., PhDGerven J.M.A. van, prof. dr.Cohen A.F., prof. dr.Universiteit Leiden (UL)2014Cannabinoids; THC; CB1 antagonists; Pharmacokinetics; Clinical pharmacology; Pharmacodynamics; Feeling high; PK-PD modelling; Resting state FMRI; Rimonabant;
Cognition in Huntington's disease : the influence of motor behaviour and time Hart E.P. 't, PhDRoos R.A.C., prof. dr.Universiteit Leiden (UL)2013Huntington's disease; Cognition; Movement disorder; Executive functioning; Memory; P300; Motor behaviour
Clinical pharmacology of nevirapine in HIV-infected patients in TanzaniaMuro E.P., PhDBurger D.M., prof. dr.Dolmans W.M.V., prof. dr.Radboud Universiteit (RU)2014Clinical pharmacology; HIV; Pharmacokinetics; therapy drug monitoring
Assessment of ischaemia and reperfusion injuryWouters C.W., PhDRongen G.A., prof. dr.Oyen W.J.G., prof. dr.Radboud Universiteit (RU)2013Ischemia/reperfusion injury; adenosine; atorvastatin; forearm;
The role of efflux and influx transporters in the disposition of digitalis-like compoundsGozalpour E., PhDRussel F.G.M., prof. dr.Radboud Universiteit (RU)2015
The many faces of Na+, K+-ATPase: understanding the role of human isoforms in health and diseaseWeigand K.M., PhDRussel F.G.M., prof. dr.Radboud Universiteit (RU)2015
Vascular adaptation to pregnancy and relaxinDrongelen J. van, PhDSmits P., prof. dr.Lotgering F.K., prof. dr.Radboud Universiteit (RU)2014
Medication safety through information technology; a focus on medication prescribing and administering.Helmons P.J., PhDKosterink J.G.W., prof. dr.Daniels C.E., prof. dr.Rijksuniversiteit Groningen (RUG)2014medication safety information technology prescribing and administering drugs
Optimizing cancer therapy. A focus on molecular imagingGaykema S.B.M., PhDVries E.G.E. de, prof. dr.Lub-de Hooge M.N., dr.Rijksuniversiteit Groningen (RUG)2014
Novel biomarker panels in diabetic kidney disease: predicting disease progression and response to therapy, and monitoring drug effectPena M.J., PhDZeeuw D. de, prof. dr.Lambers Heerspink H.J., prof. dr.Rijksuniversiteit Groningen (RUG)2015Biomarkers; Diabetes mellitus; Kidney;
Integrating biomarkers to predict renal and cardiovascular drug efficacy: PRE score applications from drug registration to personalized medicineSchievink B.H., PhDZeeuw D. de, prof. dr.Lambers Heerspink H.J., prof. dr.Rijksuniversiteit Groningen (RUG)2016PRE score; Risk markers; Chronic kidney disease; Personalized medicine;
The association between albuminuria and long-term renal risk; how to improve the precision of drug effect estimatesKröpelin T.F., PhDZeeuw D. de, prof. dr.Lambers Heerspink H.J., prof. dr.Rijksuniversiteit Groningen (RUG)2016Kidney; Diabetic kidney disease; Drug efficacy;
Experimental focal cerebral ischemia: optimalisation of models and therapeutic interventionsShanbhag N.C., PhDHenning R.H., prof. dr.Schilling L., prof. dr.Rijksuniversiteit Groningen (RUG)2016Cerebral ischemia;
Pharmacological modulation of ischemia and reperfusion injuryMeijer P., PhDRongen G.A., prof. dr.Smits P., prof. dr.Radboud Universiteit (RU)2012Ischemia/Reperfusion injury; rosuvastatin; adenosine; forearm;
Human in vivo studies on the non-glycaemic effects of thiazolidinedione derivativesRennings A.J.M., PhDSmits P., prof. dr.Tack C.J.J., prof. dr.Radboud Universiteit (RU)2014
Exposure to antiretroviral agents in hiv-infected pregnant women: not too much-not too littleColbers E.P.H., PhDBurger D.M., prof. dr.Radboud Universiteit (RU)2015HIV; antiretroviral agents; clinical pharmacology; drug drug interactions
Making things easier: how to improve antiviral drug treatment for childrenBastiaans D.E.T., dr.Burger D.M., prof. dr.Radboud Universiteit (RU)2016Clinical pharmacology; Antiviral drug treatment;
Size does matter : drug glucuronidation in childrenKrekels E.H.J., PhDKnibbe C.A.J., prof. dr.Tibboel D., prof. dr.Universiteit Leiden (UL)2012Paediatrics; Morphine; Population PK; System-specific covariate modelling; Model validation; Glucuronidation; Ontogeny; Pharmacokinetics; UGT2B7; Zidovudine;
Pain still hurts : pain assessment and pain management in intensive care patientsAhlers S.J.G.M., PhDTibboel D., prof. dr.Knibbe C.A.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2012Morphine; Remifentanil; Pain; Immune reconstitution; Intensive care; Critically ill; Analgesia; Anesthesiology; Pain assessment; Pain management;
Exploring optimal pharmacotherapy after bariatic surgery: where two worlds meetYska J.P., PhDRoon E.N. van, prof. dr.Wilffert B, prof. dr.Rijksuniversiteit Groningen (RUG)2017Optimal pharmacotherapy; Bariatric surgery;
Modulation of endogenous H2S productin: its role in hibernation and pharmacological cell protectionTalaei F., PhDHenning R.H., prof. dr.Schmidt M., prof. dr.Rijksuniversiteit Groningen (RUG)2012Hibernation; Endogenous H2S production; Pharmacological cell protection; Hypothermia; Cysteinyldopa;
Off-target effects of RAAS-inhibition: importance on renal outcomes in patients with diabetesMiao Y., PhDGroen A.K., prof. dr.Zeeuw D. de, prof. dr.Rijksuniversiteit Groningen (RUG)2012RAAS-inhibition; Diabetes mellitus;
Renin-Synthesizing Cells and BeyondGoes Martini A., PhDDanser A.H.J., prof. dr.Neves F.A.R., prof. dr.Erasmus Universiteit Rotterdam (EUR)2017Renin-angiotensin system; Renal function;
Endothelial dysfunction in cardiovascular diseaseHeuvel M. van den, PhDDuncker D.J.G.M., Prof.dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2018Cardiovascular disease; Vascular reactivity; Cholesterol;
Evaluation of renal end points in nephrology trials. Weldegiorgis MLambers Heerspink H.J., prof. dr.Zeeuw D. de, prof. dr.Rijksuniversiteit Groningen (RUG)2017Pharmacology; Nephrology trials; renal endpoints
Advanced vascular imaging : technical and clinical applications in type 2 diabetesBoer S.A. de, PhDKamphuisen T.P.W., prof. dr.Slart R.H.J.A., prof. dr.Rijksuniversiteit Groningen (RUG)2017Pharmacology; advanced vascular imaging; Diabetes mellitus;
Albuminuria: more than a renal risk marker? Belt S.M. van den, PhDZeeuw D. de, prof. dr.Lambers Heerspink H.J., prof. dr.Rijksuniversiteit Groningen (RUG)2018Albuminuria; Risk markers;
Towards understanding interchangeability of generic drugsYu Y, drNeef C., prof. dr.Burger D.M., prof. dr.Universiteit Maastricht (UM)2017
Pharmacy Preparations: European quality standards and regulationScheepers H., drNeef C., prof. dr.Universiteit Maastricht (UM)2017Pharmacy policy;
Medication management in homecare patientsSino C.G.M., PhDSchuurmans M.J., prof. dr.Egberts A.C.G., prof. dr.Universiteit Utrecht (UU)2013
Pharmacological approaches to optimize TB treatmentZuur M.A.Alffenaar J.W.C., prof. dr.Werf T.S. van der, prof. dr.Rijksuniversiteit Groningen (RUG)2018Optimize; Tuberculosis; Treatment;
The pursuit of user-friendly medicines : older people in the hot seatNotenboom K., PhDBouvy M.L., prof. dr.Leufkens H.G.M., prof. dr.Universiteit Utrecht (UU)2017Usability; User-friendly; Older patients; Elderly; Medicines; Medication use; Medication errors; Tablet breaking; Swallowing; Medication packaging;
Clinical pharmacology of novel anticancer drug formulationsStuurman F.E, PhDSchellens J.H.M., prof. dr.Beijnen J.H., prof. dr.Universiteit Utrecht (UU)2013Clinical pharmacology; Cancer;
Use of real-world evidence in pharmaeconomic analysisHuang Y.Haaijer-Ruskamp F.M., prof. dr.Postma M.J., prof. dr.Rijksuniversiteit Groningen (RUG)2019Pharmacogenomics;
Therapeutic drug monitoring in tuberculosis treatmentElsen S.H.J. van denAlffenaar J.W.C., prof. dr.Werf T.S. van der, prof. dr.Rijksuniversiteit Groningen (RUG)2020drug monitoring, tuberculosis treatment
Implementing dried blood spot sampling in transplant patient careTouw D.J., prof. dr.Touw D.J., prof. dr.Bakker S.J.L., prof. dr.Rijksuniversiteit Groningen (RUG)2020dried blood spot sampling, transplant patient care
Characterization and re-evaluation of experimental pain models in healthy subjectsSiebenga P.SCohen A.F., prof. dr.Universiteit Leiden (UL)2020Analgesics Human evoked pain models Neuropathic pain Nociceptive pain Pharmacodynamics Phase-1 clinical triala
Future drugs in atherosclerotic cardiovascular diseasePoelgeest E.P vanBurggraaf J., prof. dr.Cohen A.F., prof. dr.Universiteit Leiden (UL)2018Atherosclerosis Systemic inflammation Hypercholesterolemia PCSK9 inhibitor TLR4 sinaling Acute kidney injury Endothelial dysfunction Human endotoxemia model Ex vivo LPS challenge test Invivo LPS challenge test
The use of a battery of evoked pain models in early phase drug developmentOkkerse P.Cohen A.F., prof. dr.Groeneveld G.J., prof. dr.Universiteit Leiden (UL)2018Pain Human pain models Analgesics Clinical pharmacology Pharmacodynamics Drug Development
Go to page:
  • of 6